Dimitri Drekonja, MD, MS

Academic Title

Associate Professor of Medicine

Administrative Contact

General Information
E: drek0002@umn.edu
P: (612) 467-4185
F: (612) 727-5995

Mailing Address
Minneapolis VA Health Care System
Infectious Diseases Section, 111F
One Veterans Drive
Minneapolis, MN 55417

Bio Statement

Dimitri Drekonja, MD, MS is an Associate Professor of Medicine and member of the Infectious Disease Section at the Minneapolis VA Health Care System (MVAHCS). Dr. Drekonja completed his internal medicine residency, chief resident year (MVAHCS), and infectious disease fellowship at the University of Minnesota. He is currently leading a VA-funded trial of treatment duration for men with urinary tract infections, and is co-chair of VA Cooperative Studies Program Study #2004, "Microbiota vs. Placebo After Antimicrobial Therapy for Recurrent Clostridium difficile at Home" (MATCH). Administrative duties include chairing the Minneapolis VA IRB "A" Committee and serving on the Infectious Diseases Society of America Public Health Committee.


Peer Reviewed Publications

  • Drekonja DM, Kuskowski MA, Anway R, Johnston BD, Johnson JR. The niche for Escherichia coli sequence type 131 among veterans: urinary tract abnormalities and long-term care facilities. Open Forum Inf Dis. 2016, in press.
  • Goodman C, O'Rourke N, Amundson C, Drekonja DM. Patient knowledge and attitudes regarding fecal microbiota therapy for Clostridium difficile infection. Fed Pract. 2016, in press.
  • Drekonja DM, Reich J, Gezahegn S, Greer N, Shaukat A, MacDonald R, Rutks I, Wilt TJ. Fecal Microbiota Transplantation for Clostridium difficile Infection – A Systematic Review. Ann Intern Med. 2015 May 5;162(9):630-8. PMID: 25938992
  • Drekonja DM, Filice GA, Greer N, Olson A, MacDonald R, Rutks I, Wilt TJ. Antimicrobial stewardship in outpatient settings: a systematic review. Infect Control Hosp Epidemiol. 2015 Feb;36(2):142-52. PMID: 25719187
  • Eccles-Radtke C, Rector TS, Cutting A, Drekonja DM. Urinary tract infections in male veterans with HIV. Open Forum Inf Dis. 2014 Nov 5;1(3). PMID: 25734168
  • Drekonja DM. Clostridium difficile infection-- current, forgotten, and emerging treatment options. J Comp Eff Res. 2014 Sep;3(5):547-57. PMID: 25350805
  • Wagner B, Filice GA, Drekonja DM, Greer N, MacDonald R, Rutks I, Butler M, Wilt TJ. Antimicrobial stewardship programs in inpatient hospital settings: a systematic review. Infect Control Hosp Epidemiol. 2014 Oct;35(10):1209-28. PMID: 25203174
  • Drekonja DM, Gnadt C, Kuskowski MA, Johnson JR. Urine cultures among hospitalized veterans: casting too broad a net? Infect Control Hosp Epidemiol. 2014 May;35(5):574-6. PMID: 24709728
  • Drekonja DM, Beekman SE, Elliott S, Mukundan D, Polenakovik H, Rosenthal ME, et al. Challenges in the management of infections due to carbapenem-resistant Enterobacteriaceae. Infect Control Hosp Epidemiol. 2014 Apr;35(4):437-9. PMID: 24602953
  • Drekonja DM. Erysipelothrix bacteremia without endocarditis: rare event or under-reported occurrence? Diagn Microbiol Infect Dis. 2013 Nov;77(3):280-1. PMID: 23988830